Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children
NCT03639142 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2018-08-23
Summary
Children with functional constipation according to the Rome IV criteria will be randomly assigned to receive prunes at dose 3.5 g/kg/d (prune group) or Polyethylene Glycol 4000 (PEG group) at dose 0.5 g/kg/d for 4 weeks. Before treatment children with impaction will receive PEG 4000 at the dose 1.5 g/kg for 3-5 consecutive days. The primary outcome measure will be treatment success, defined as ≥3 BM per week with no fecal soiling during last week of the intervention.
Conditions
- Functional Constipation
Interventions
- OTHER
-
Prunus domestica
Patients will receive prunes at dose 3,5 g/kg/d (max.100mg/day) in three portions a day, for 4 weeks (amount of prescribed prunes will be calibrated with the weight that child ought to have on WHO growth charts at 50th percentile). Prunes should be introduced every day in three meals. Prunes can be chopped or grinded before eating them. They can be eaten alone or child may eat them as a part of bigger meal (which is preferred version). Prunes can be introduced with yogurt, cereals, nuts and seeds as a morning meal.
- DRUG
-
Polyethylene Glycol 4000
Patients will receive PEG at dose 0,5 g/kg/d once daily orally, for 4 weeks.
Sponsors & Collaborators
-
Medical University of Warsaw
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2020-09-01
- Completion
- 2020-11-01
More Related Trials
-
PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children
NCT00153114 ·Status: COMPLETED ·Phase: PHASE4
-
To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.
NCT00255372 ·Status: COMPLETED ·Phase: PHASE3
-
Prucalopride in Paediatric Subjects, With Functional Faecal Retention
NCT01670669 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children
NCT01592734 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications
NCT00153127 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months
NCT02751411 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Trial of Enema vs. PEG 3350 for Constipation
NCT00467350 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years.
NCT03177434 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Prucalopride For Functional Constipation in Children and Teenagers
NCT04759833 ·Status: TERMINATED ·Phase: PHASE3
-
A Trial of Actazin Versus PEG 3350 for Maintenance Therapy in Children With Constipation
NCT06836024 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of the Safety and Tolerability of Prucalopride in Constipated Elderly Subjects Living in a Nursing Facility
NCT00627692 ·Status: COMPLETED ·Phase: PHASE2
-
The Inside Study: Oligosaccharides Versus Placebo in Functional Constipation
NCT04282551 ·Status: UNKNOWN ·Phase: NA
-
Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention
NCT01674166 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing PEG 3350 Laxative to Placebo in the Treatment of Occasional Constipation (Study CL2007-12)(P08216)
NCT00770432 ·Status: COMPLETED ·Phase: PHASE4
-
Different Bowel Preparations for Colonoscopy In Children
NCT01711437 ·Status: UNKNOWN ·Phase: PHASE4
-
Movicol in Childhood Constipation (ProMotion Study)
NCT00404040 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Triple Management Program in the Management of Functional Chronic Constipation in Children
NCT06082622 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation
NCT00631813 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation
NCT00488137 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Prucalopride in Patients With Severe Chronic Idiopathic Constipation
NCT00576511 ·Status: COMPLETED ·Phase: PHASE2
-
RCE With FMT in the Treatment of Childhood Constipation
NCT05035784 ·Status: COMPLETED ·Phase: NA
-
Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects
NCT03279341 ·Status: COMPLETED ·Phase: PHASE4
-
PEG Versus PEG+Bisacodyl Versus Sennosides for Colon Cleansing Before Colonoscopy
NCT01531140 ·Status: COMPLETED ·Phase: PHASE4
-
Glucomannan for Childhood Functional Constipation.
NCT01151878 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation
NCT00603681 ·Status: COMPLETED ·Phase: PHASE4